Global Blood Therapeutics prices a $150.0 million common stock public offering
Global Blood Therapeutic announced the pricing of its underwritten public offering of its common stock for gross proceeds of $150.0 million. GBT has granted the underwriters a 30-day option to purchase $22.5 million of additional shares of common stock. December 07, 2018